Everand Logo

Welcome to Everand!

  • STAT

    A pivotal test of malaria vaccine is set to begin. Can it live up to its promise?

    Some officials believe a vaccine can dramatically lower the number of #malaria cases worldwide. Can it live up to its promise?
    by Helen Branswell Apr 19, 2019 4 minutes
    A child suffering from malaria sleeps under a mosquito net in a hospital in western Kenya.

    Researchers are preparing to launch a pivotal test of an important malaria vaccine this month — one that global health leaders believe could eventually lead to big reductions in the number of cases and deaths worldwide.

    Despite those high hopes, there are also concerns that the theoretical benefits of the vaccine, made by GSK, might not translate into the real world.

    To see whether the vaccine lives up to its promise, the World Health Organization and partners have designed a sort of beta rollout of the vaccine, called RTS,S. Beginning April 23, Malawi is expected to start using the vaccine in its routine immunization programs for children. Ghana

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related Books & Audiobooks